Because of the potential for serious adverse reactions in nursing infants a decision should be made whether to discontinue breast- feeding or Extavia therapy.
A causa de la posible inducción de reacciones adversas graves en los lactantes, se debe decidir si interrumpir la lactancia o el tratamiento con Extavia.